FarmaMondo Partners with Cordex to Expand Zemcelpro
LUGANO, Switzerland & MONTREAL, Canada, July 16, 2026 FarmaMondo Group has entered an exclusive commercial partnership with Cordex Biologics...
kidney disease
Advertisement
Dimerix Secures Funding to Advance DMX-200 Phase 3 Trial
MELBOURNE, Australia, July 17, 2026 Dimerix Limited has secured an initial AU$10 million non-dilutive loan facility to strengthen its...
Novartis Fabhalta Wins Full FDA Approval for IgAN
BASEL, July 17, 2026 Novartis announced that the U.S. Food and Drug Administration (FDA) has granted traditional approval for...
Persephoni Backs SelSym to Advance Trauma Bleeding Care
RESEARCH TRIANGLE PARK, N.C., July 15, 2026 Persephoni BioSciences has announced a strategic investment in SelSym Biotech, bringing the...
Genentech Wins FDA Priority Review for Gazyva in pMN
SOUTH SAN FRANCISCO, Calif., July 14, 2026 Genentech, a member of the Roche Group, has received U.S. Food and...
Advertisements
Roche’s Gazyva Receives FDA Priority Review
BASEL, Switzerland, July 15, 2026 Roche announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review...
Otsuka Advances VOYXACT Toward Traditional FDA Approval with Phase 3 Success
PRINCETON, N.J. and TOKYO, Japan, July 1, 2026 Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd....
Alexion’s Ultomiris Gets FDA Priority Review for IgAN
BOSTON, US | June 15, 2026 Alexion, AstraZeneca Rare Disease announced that the U.S. Food and Drug Administration (FDA)...
Edesa Biotech Reports Positive Paridiprubart AKI Data
TORONTO, June 5, 2026 Edesa Biotech, Inc. announced new exploratory analyses demonstrating positive clinical signals for paridiprubart (EB05), its...
Climb Bio Advances CLYM116 After Encouraging Phase 1 Safety Results
WELLESLEY HILLS, Mass., June 5, 2026 Climb Bio, Inc. announced the presentation of initial Phase 1 safety data and...
Advertisement
